It was also revealed that this high stereoselectivity results from the difference in K m values, and not V max values, between the enantiomers. The observed stereoselectivity was consistent with the differences in the intestinal absorption of MTX enantiomers in humans.
Introduction
Folates are essential nutrients for cell growth that are transported across the cell membrane by the reduced folate carrier (RFC, SLC19A1) or the proton-coupled folate transporter (PCFT, SLC46A1) in various mammalian cells. [1] [2] [3] [4] The cDNA of RFC has been cloned in mice, hamsters, and humans, and its transport characteristics have been ascertained. [5] [6] [7] [8] [9] [10] [11] RFC transports only reduced folates, and not oxidized folates, and maximal folate transport is observed at neutral pH. 2, 4, 12) PCFT was originally identified as the heme carrier protein (HCP). However, it was subsequently revealed that folates are good substrates of PCFT. 3) PCFT is expressed in the epithelial cells of the small intestine and is involved in the absorption of both reduced and oxidized folates using an H ＋ gradient as the driving force. 12) Because the microclimate pH at the surface of epithelial cells is acidic, PCFT may play a major role in the intestinal absorption of folates.
Methotrexate (L-amethopterin, L-MTX) is clinically used as an antineoplastic and antirheumatic drug. Because its molecular structure is similar to folic acid (FA), orally administered L-MTX is absorbed by RFC or PCFT in the small intestine. D-Amethopterin (D-MTX) is the optical isomer of L-MTX, and the absorption of D-MTX from the human small intestine is significantly lower than that of L-MTX. It has been reported that the area under the plasma concentration-time curve (AUC) following oral administration of L-MTX is approximately 40-fold greater than that following oral administration of an equal dose of D-MTX. 13) In our previous studies using Caco-2 cells, we examined the inhibitory effects of unlabeled L-and D-MTX on the uptake of [ 3 H]-L-MTX. Both L-and D-MTX competitively inhibited carrier-mediated transport, with the Ki value of D-MTX being more than 100-fold greater than that of L-MTX. The results showed that the affinity of L-MTX to the carrier was more than 100-fold greater than that of D-MTX. 14, 15) The uptake of L-and D-MTX into Caco-2 cells was also measured using liquid chromatography-tandem mass spectrophotometry (LC-MS/MS) analysis, which revealed that the uptake of L-MTX was at least 7-fold greater than that of D-MTX. 15) Because the uptake of MTX enantiomers was measured at pH 6.0, it was suggested that the observed stereoselectivity may reflect that of PCFT, and not of RFC.
In the present study, human embryonic kidney HEK293 cells stably expressing PCFT were established. In order to determine the stereoselectivity of PCFT, uptake of MTX enantiomers into PCFT-HEK293 cells was measured by conducting LC-MS/MS analysis.
Materials and Methods
Materials: Methotrexate (L-amethopterin, L-MTX) was purchased from Nacalai Tesque (Kyoto, Japan). Construction of stably transfected HEK293 cells expressing human PCFT: PCFT cDNA was cloned from Caco-2 cells by reverse transcription and subsequent polymerase chain reaction (PCR). Next, 1 mg of the total RNA was heat-denatured with 1 mL of random primer at 709 C for 5 min; placed on ice for 1 min; and then mixed with 5 mL of Moloney murine leukemia virus (M-MLV) reverse transcriptase 5× reaction buffer, 1.5 mL of 10 mM dNTP mixture, and 0.2 mL of M-MLV reverse transcriptase (Promega, Madison, WI, U.S.A.). The mixture was incubated at 379 C for 60 min, followed by incubation at 709 C for 15 min. The following oligonucleotide primers were used: human PCFT (hPCFT) (forward) 5?-GCTCCGCCGCGCACGCACAT-3?, (reverse) 5?-TCAGGGGCTCTGGGGAAACTGC-3?. The reaction mixture (50 mL) contained 1 mL of RT product as the template DNA, 10 pmol of each forward and reverse primer, 10 nmol dNTP mixture, 10× highfidelity PCR buffer, and 1 unit of Platinum Taq DNA polymerase high fidelity. After initial denaturation at 949 C for 2 min, the targeted nucleotides were amplified for 30 cycles (hPCFT), with denaturation at 949 C for 30 s, annealing at 559 C for 30 s, extension at 729 C for 2 min, and final extension at 729 C for 10 min. The amplified cDNA product was subcloned into pGEM-T Easy vector (Promega) and transferred into a mammalian expression vector, pcDNA3.1(＋) (Invitrogen Co., Grand Island, NY, U.S.A.).
hPCFT-expressing HEK293 cells and control cells (Mock) were constructed by transfecting the expression vector and control pcDNA3.1 vector, respectively, into cells using FuGENE6 (Roche Diagnostics, Indianapolis, IN, U.S.A.), according to the manufacturer's instructions; transformants were selected by using 600 mg/mL of antibiotic G418 sulfate (Nacalai Tesque, Kyoto, Japan) for 2 weeks.
Cell culture: HEK293 cells were obtained from the Cell Resource Center for Biomedical Research, Tohoku University (Sendai, Japan). The cells were maintained at 379 C in a humidified atmosphere containing 5% of CO2. Culture medium consisted of Dulbecco's modified Eagle's medium, 100 U/mL penicillin, 100 mg/mL streptomycin, and 10% fetal bovine serum.
PCFT-HEK293 cells and HEK293-Mock cells were grown in Dulbecco's modified Eagle's medium containing 100 U/mL penicillin, 100 mg/mL streptomycin, 600 mg/mL antibiotic G418 sulfate, and 10% fetal bovine serum. Cells were seeded in multiple-well plates coated with poly-D-lysine at a density of 1.0×10 5 cells/well. Uptake study: Hank's balanced salt solution (HBSS: 145 mM NaCl, 3 mM KCl, 1 mM CaCl2, 0.5 mM MgCl2) containing 5 mM D-glucose and 5 mM MES (pH 6.0) was used as the uptake medium. HBSS containing 5 mM D-glucose and 5 mM HEPES (pH 7.4) was used as the rinse medium.
For the uptake study, PCFT-HEK293 cells and HEK293-Mock cells in multiple-well plates were rinsed twice and preincubated with the rinse medium (pH 7.4) for 10 min at 379 C. Uptake was initiated by adding 0.5 mL of the preincubated drug solution. The uptake medium (pH 6.0) containing [ 3 H]-L-MTX, unlabeled L-MTX, D-MTX, or FA was used as the drug solution. The drug solution was aspirated at the appropriate time to terminate the uptake. The cells were rinsed twice with ice-cold rinse medium (pH 7.4), and then lysed with 1 mL of 0.1% Triton X-100. To determine the uptake amount of [ 3 H]-L-MTX, a 0.8-mL aliquot of the cell lysate was transferred to a scintillation vial, to which 5 mL of Clear-sol I (Nacalai Tesque) was added, and the radioactivity was measured by liquid scintillation counting. To determine the uptake amount of D-MTX, a 1-mL aliquot of the cell lysate was mixed with 1 mL of acetonitrile and then vortexed. The mixture was then centrifuged at 825 g for 15 min, and the supernatant was filtered using a Millex-HV filter (0.45 mm; Millipore, Bedford, MA, U.S.A.). The filtrate was dried under a gentle stream of nitrogen gas at 809 C, and the residue was dissolved in 100 mL of the mobile phase (see below). 16) A 20-mL aliquot was injected into an LC-MS/MS system.
In the inhibition study, each inhibitor was added to the drug solution at an appropriate concentration, and uptake of the drug was measured in the same manner as described above. Drugs and inhibitors were dissolved in dimethylsulfoxide (DMSO), and the final concentration of DMSO in the drug solution was 1% or less. 
LC-MS/MS conditions:
A Waters Micromass tandem quadrupole Quattro micro mass spectrometer (Waters, Milford, MA, U.S.A.) was interfaced with the HPLC system via an electrospray ionization probe in the negative ion mode. The analytical column used for HPLC was Inertsil ODS-3 (5 mm in particle size, 2.1×150 mm; GL Sciences Inc., Tokyo, Japan). The mobile phase was solvent A (10 mM ammonium acetate, 0.05% formic acid, and 1% isopropyl alcohol in water) and solvent B (0.05% formic acid and 1% isopropyl alcohol in acetonitrile) in the proportion of 9:1 (v/v). The flow rate was adjusted to 0.2 mL/min, and an eluent between 4 and 10 min was introduced into the mass spectrometer. The ionization conditions were as follows: capillary voltage, 2.9 kV; cone voltage, 46 V; collision energy, 22 eV; source temperature, 1509 C; desolvation temperature, 2209 C; collision gas, argon. The sample was analyzed during the multiple reaction monitoring (MRM) mode of the mass spectrometer at a dwell time of 2 s per channel using m/z 453.08À324.08 as the transition.
Protein assay: For protein determination, PCFT-HEK293 cells and HEK293-Mock cells were dissolved in 1 mL of 0.1% Triton X-100, and the protein concentration was determined using a Bio-Rad protein assay kit (Bio-Rad Laboratories, Richmond, CA, U.S.A.) with bovine serum albumin as a standard. Data analysis: To calculate the kinetic parameters for L-MTX and D-MTX uptake, the data were fit to the following equation by a non-linear least-squares method. 17) v＝
Vmax･
where v is the carrier-mediated initial uptake rate, Vmax is the maximum uptake rate, Km is the Michaelis constant, and [S] is the initial concentration of the drug.
Results
Uptake of L-MTX: Figure 1A shows the time course of 0.02 mM Figure 1A , the initial uptake rate was calculated from the uptake amount at 2 min in the following analyses. Figure 1B shows the pH-dependent uptake of 0.02 mM Figure 2A . An Eadie-Hofstee plot of the PCFTmediated uptake indicated that the saturable uptake of L-MTX was mediated by a single transport system (Fig.  2B) . The uptake parameters calculated according to Eq. 1 were as follows: Km＝4.98±0.80 mM, Vmax＝891±83 pmol/min/mg protein [mean±standard deviation (S.D.), n＝3].
Inhibition studies: The initial uptake rates of 0.25, 0.4, and 1 mM [ 3 H]-L-MTX were measured in the presence of 0, 4, and 8 mM unlabeled L-MTX, and the data were analyzed using a Dixon plot (Fig. 3A) . Unlabeled L-MTX competitively inhibited [ MTX uptake with a Ki value of 185 mM (Fig. 3B) . Furthermore, the initial uptake rates of 0.25, 0.4, and 1 mM ]-L-MTX uptake competitively with a Ki value of 2.14 mM (Fig. 3C) . Uptake of D-MTX: Figure 4A shows the time course of 10 mM D-MTX uptake in PCFT-HEK293 and Mock cells. The uptake into PCFT-HEK293 cells was significantly higher than that into Mock cells. On the basis of the results in Figure 4A , the initial uptake rate was calculated from the uptake amount at 1 min in the following analyses. Figure 4B shows the pH-dependent uptake of 10 mM D-MTX. Uptake was measured at extracellular pH levels ranging between 5.0 and 7.4; it was found to be the highest at pH 5.0 and decreased with an increase in the extracellular pH.
The initial uptake rates of D-MTX at various concentrations (10-1000 mM) were measured in the presence of an H ＋ gradient (pH 6.0). PCFT-mediated uptake was calculated by subtracting the uptake into Mock cells from that into PCFT-HEK293 cells. The results are shown in Figure 5A . An Eadie-Hofstee plot of the PCFT-mediated uptake indicated that the saturable uptake of D-MTX was mediated by a single transport system (Fig. 5B) . The uptake parameters calculated according to Eq. 1 were as follows: Km＝211±19 mM, Vmax＝909±54 pmol/min/ mg protein (mean±S.D., n＝3).
Discussion
In our previous research using Caco-2 cells, we studied the inhibitory effects of unlabeled L-and D-MTX on the uptake of [ The results showed that the affinity of L-MTX was more than 100-fold greater than that of D-MTX. 14, 15) The uptake of L-and D-MTX into Caco-2 cells was also measured using LC-MS/MS analysis, which revealed that L-MTX uptake was at least 7-fold greater than that of D-MTX. 15) Since the uptake of L-MTX into Caco-2 cells was measured at an extracellular pH of 6.0, we assumed that PCFT, and not RFC, was the carrier responsible for the stereoselective uptake of MTX enantiomers. It was likely that the observed stereoselectivity in the uptake of MTX enantiomers into Caco-2 cells reflected that of PCFT.
In the present study, HEK293 cells stably expressing PCFT were established to confirm the stereoselective PCFT-mediated uptake of MTX enantiomers. Since isotope-labeled D-MTX was not commercially available, uptake of D-MTX was measured by using LC-MS/MS analysis.
Uptake of L-MTX mediated by PCFT was highly pHdependent (Fig. 1B) . The uptake was higher at low pH, and it declined as the pH increased. The observed pHdependent uptake by PCFT is consistent with other reports. 3, 18) The Km value (4.98 mM) for L-MTX in the present study (Fig. 2) was similar to those reported previously, i.e., 3.4 mM in Xenopus oocytes injected with human PCFT cRNA, 3) 3.67 mM in HEK293 cells transfected with human PCFT cDNA, 18) and 1.0-4.6 mM and 0.6-2.6 in HepG2 cells transfected with mouse and rat PCFT cDNA, respectively. 19) The Dixon plot showed that L-MTX uptake was inhibited competitively by unlabeled L-MTX with a Ki value of 3.58 mM (Fig. 3A) . This Ki value is almost equal to the Km value (4.98 mM) of L-MTX (Fig. 2) . D-MTX also competitively inhibited the uptake of L-MTX with a Ki value of 185 mM (Fig. 3B) . The Dixon plot for the inhibition effect of FA on L-MTX uptake showed that FA competitively inhibited L-MTX uptake, with a Ki of 2.14 mM (Fig.  3C) . This Ki value was almost equal to the Km value of FA that was observed in our laboratory (1.90 mM, data not shown). The results clearly demonstrate that the affinity of L-MTX to PCFT is comparable to that of FA, and that the affinity of D-MTX to PCFT is approximately 50-fold smaller than that of L-MTX. These results are consistent with our previous observations in Caco-2 cells, which showed that the affinity of L-MTX to the carrier was comparable to that of FA and was approximately 100-fold greater than that of D-MTX. 14, 15) The pH-dependent uptake of D-MTX by PCFT was similar to that of L-MTX (Figs. 1B and 4B) . Uptake of D-MTX by PCFT was higher at lower pH, and it declined as the pH increased. The Km value (211 mM) for D-MTX uptake (Fig. 5) was almost equal to the Ki value (185 mM, Fig. 3B ). The comparison of the Km values between L-MTX (4.98 mM, Fig. 2 ) and D-MTX (211 mM) again revealed that the affinity of L-MTX to PCFT was approximately 40-fold greater than that of D-MTX.
The PCFT-mediated uptake clearance of L-MTX and D-MTX was calculated as Vmax/Km, which was 179 and 4.31 mL/min/mg protein, respectively. The ratio of the PCFTmediated uptake clearance of L-MTX to that of D-MTX was approximately 40. Since the Vmax value of L-MTX (891 pmol/min/mg protein) was similar to that of D-MTX (909 pmol/min/mg protein), the 40-fold difference in the uptake clearance between the enantiomers was thought to have resulted from the differences in the Km values.
When an equal dose of each amethopterin enantiomer was orally administered to humans, the area under the plasma concentration-time curve (AUC) of L-MTX was approximately 40-fold greater than that of D-MTX. 13) Because the elimination rate constant of D-MTX was only 1.7-fold greater than that of L-MTX following intravenous administration of each enantiomer, the marked difference in AUC between the enantiomers following oral administration was probably attributable to stereoselective intestinal absorption. These observations in humans are consistent with the significant stereoselectivity of PCFT observed in the present study.
PCFT is expressed in various tissues such as the liver, kidney, and placenta, and it appears to be expressed abundantly in the small intestine. 3, 19) PCFT is localized at the apical membrane of the intestinal epithelial cells that have a surface microclimate pH of about pH 6.0. 20, 21) Therefore, it is considered that the intestinal absorption of folates and methotrexate is mainly mediated by PCFT, and not by RFC. In addition to PCFT, methotrexate is known to be a substrate of MRPs (multi-drug resistanceassociated proteins) and BCRP (breast cancer resistance protein). In the small intestinal epithelial cells, MRP2 and BCRP are localized at the apical membrane, and MRP3 is localized at the basal membrane. [22] [23] [24] It has been reported that both L-and D-MTX are transported by rat mrp2 and that the affinity of D-MTX to rat mrp2 is 3.5-fold greater than that of L-MTX. 25) It has also been reported that MRP3 is responsible for the efflux of methotrexate across the basal membrane. 26) The stereoselectivity of MRP3 during the efflux of L-and D-MTX has not yet been elucidated. However, considering the broad substrate specificity of MRPs, it is reasonable to assume that MRP3 does not have a high stereoselectivity. In any case, the roles of MRPs and BCRP in stereoselective intestinal absorption will have to be clarified in future studies.
The present study revealed for the first time the significant stereoselectivity of the PCFT-mediated transport of MTX enantiomers using PCFT-expressing cells. The significant stereoselectivity resulted from the difference in the affinity (Km value) between the enantiomers, although their transport efficiencies (Vmax value) were similar. The results also indicated that the stereoselectivity of the PCFT-mediated transport of MTX enantiomers is responsible for stereoselective intestinal absorption. The present study suggests that the stereoselectivity of drug transporters may result in significant stereoselectivity in the absorption and disposition of chiral drugs.
